Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28525794 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL812355 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL10942415 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL17559518 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL10942290 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL10943444 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL8953912 | 0.95 | ALDH1A1 (0.68) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL8674186 | 0.88 | ALDH1A1 (0.62) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL8672267 | 0.88 | ALDH1A1 (0.62) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL4349942 | 0.87 | ALDH1A1 (0.57) | ALDH1A1TDP1SMN1; SMN2TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9868793-B2 | Cationic group-containing cellulose ether | KAO CORPORATION (JP) | 2018-01-16 | — | — | US | disclosed |
| EP-3010591-B1 | CATIONIC GROUP-CONTAINING CELLULOSE ETHER | KAO CORP (JP) | 2017-04-12 | — | — | EP | disclosed |
| US-20160122441-A1 | CATIONIC GROUP-CONTAINING CELLULOSE ETHER | KAO CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| EP-3010591-A1 | CATIONIC GROUP-CONTAINING CELLULOSE ETHER | Kao Corporation (JP) | 2016-04-27 | — | — | EP | disclosed |
| CN-105142731-A | Cationic group-containing cellulose ether | KAO CORP | 2015-12-09 | — | — | CN | disclosed |
| WO-2014203548-A1 | CATIONIC GROUP-CONTAINING CELLULOSE ETHER | KAO CORPORATION (JP) | 2014-12-24 | — | — | WO | disclosed |
| US-20100168450-A1 | NOVEL BRANCHED ALKOXYLATES | THOEN JOHAN A | 2010-07-01 | — | — | US | disclosed |
| CN-101668728-A | Novel alkoxylate-containing compositions | DOW GLOBAL TECHNOLOGIES INC | 2010-03-10 | — | — | CN | disclosed |
| CN-101668726-A | New branched alkoxylates | DOW GLOBAL TECHNOLOGIES INC | 2010-03-10 | — | — | CN | disclosed |
| EP-2152653-A1 | NOVEL ALKOXYLATE-CONTAINING COMPOSITIONS | Dow Global Technologies Inc. (US) | 2010-02-17 | — | — | EP | disclosed |
| EP-2139833-A1 | NOVEL BRANCHED ALKOXYLATES | Dow Global Technologies Inc. (US) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008134390-A1 | NOVEL BRANCHED ALKOXYLATES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008134389-A1 | NOVEL ALKOXYLATE-CONTAINING COMPOSITIONS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160122441-A1 | CATIONIC GROUP-CONTAINING CELLULOSE ETHER | CUTA, UGCG, UGT8 | ALDH1A1 2257/4885TDP1 3292/4885SMN1; SMN2 1730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.